What is Wedbush’s Forecast for OVID FY2029 Earnings?
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Wedbush issued their FY2029 earnings estimates for Ovid Therapeutics in a note issued to investors on Wednesday, March 12th. Wedbush analyst L. Chico anticipates that the company will post earnings of $3.58 per share for the year. Wedbush has a “Outperform” rating and a $3.00 price target […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Wedbush issued their FY2029 earnings estimates for Ovid Therapeutics in a note issued to investors on Wednesday, March 12th. Wedbush analyst L. Chico anticipates that the company will post earnings of $3.58 per share for the year. Wedbush has a “Outperform” rating and a $3.00 price target […]
